Across all cases, overall survival and breast cancer-specific survival, unadjusted for confounders, did not vary by expression of IGF1, IGF1R, IGFBP2, or IGFBP3 (Fig.2). This evidence concerns the gene IGFBP2 and breast carcinoma.